Table 14Summary of Recommendations in Included Guidelines

Recommendations and supporting evidence Quality of evidence and strength of recommendations
Greenberg et al. (2021) 32
“Intravenous iron infusions may be appropriate for patients with IDA in certain circumstances (i.e., < 8 wk until surgery, unable to tolerate/absorb oral iron formulation, hemoglobin level < 100 g/L).”[ref]

Evidence supporting this recommendation was from 1 SR, 4 RCTs, 1 prospective cohort study, and 2 retrospective cohort studies.

Strength of recommendation: Strong

Quality of evidence: High

IDA = iron deficient anemia; RCT = randomized controlled trial; SR = systematic review.

From: Intravenous Iron Preparations for Patients Undergoing Elective Surgery: A 2022 Update

Cover of Intravenous Iron Preparations for Patients Undergoing Elective Surgery: A 2022 Update
Intravenous Iron Preparations for Patients Undergoing Elective Surgery: A 2022 Update: Rapid Review [Internet].
Hill S, Severn M; Authors.
Copyright © 2022 Canadian Agency for Drugs and Technologies in Health.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.